Curt Herberts

Curt Herberts is President and Chief Operating Officer of Kriya. Herberts joined Kriya from Senti Biosciences, Inc., where he most recently served as Chief Operating Officer and helped lead Senti to be a public company in 2022. Prior to Senti, Herberts served in a variety of leadership roles at Sangamo Therapeutics, culminating as Chief Business Officer, where he led the company’s $3B gene editing collaboration with Kite/Gilead andgene therapy collaborations with Pfizer and Biogen. Previously he was a senior executive at Campbell Alliance Group, a leading management consulting firm specializing in the life science industry.

Herberts earned his B.A. from Stanford University in human biology, and his Master of Business and Science from the Keck Graduate Institute of Applied Life Sciences.